Award

Purchase Order #HT001426PE048

Purchase Order for Transcatheter Heart Valve by Edwards Lifesciences

Buyer

Defense Health Agency

Award Amount

$34,000.00

Ceiling

$34,000.00

Awarded

February 26, 2026

Period of Performance

Feb 26, 2026 – Mar 25, 2026

Identifier

HT001426PE048

NAICS

339112

This award is a purchase order contract procured by a government agency for the acquisition of a transcatheter heart valve. The recipient, Edwards Lifesciences LLC, is a leading medical technology company specializing in innovative heart valve therapies, with this contract supporting its provision of advanced cardiovascular devices. The product acquired is a transcatheter heart valve, a minimally invasive device critical for patients requiring valve replacement procedures without open-heart surgery. This contract is significant as it enhances the agency's capability to provide cutting-edge medical treatments, reflecting ongoing efforts to improve patient outcomes with less invasive options. The scope of work covers the delivery of the specified heart valve device to be used presumably in clinical or hospital settings, ensuring timely access to essential cardiac technologies. The contract was awarded through a direct purchase order process, indicating a streamlined procurement likely due to the specialized nature of the medical device and the supplier’s established market position. The period of performance is a short-term timeline, covering approximately one month, highlighting a focused procurement event for immediate needs. The place of performance is Bethesda, Maryland, which may correlate with a healthcare facility or research institution benefiting from this award. No subcontractors or previous related contracts were noted, and no contract vehicle or solicitation details were provided for this transaction.

Description

TRANSCATHETER HEART VALVE

View original record